Blanchard Cheryl R has filed 64 insider transactions across 3 companies since March 2023.
Most recent transaction: a option exercise of 25131 shares of Anika Therapeutics, Inc. ($ANIK) on March 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Restricted Stock Unit | 25131 | $0.00 | 25,132.0000 | 14,419,000 | 50.00% | 0.17% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Common Stock | 24519 | $0.00 | 247,711.0000 | 14,419,000 | 10.99% | 0.17% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | A | Common Stock | 24520 | $0.00 | 272,231.0000 | 14,419,000 | 9.90% | 0.17% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | F | Common Stock | 14728 | $14.20 | 257,503.0000 | 14,419,000 | 5.41% | 0.10% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Common Stock | 25131 | $0.00 | 282,634.0000 | 14,419,000 | 9.76% | 0.17% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | F | Common Stock | 12104 | $14.20 | 270,530.0000 | 14,419,000 | 4.28% | 0.08% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Restricted Stock Unit | 24519 | $0.00 | 49,040.0000 | 14,419,000 | 33.33% | 0.17% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Restricted Stock Unit | 20001 | $0.00 | 0.0000 | 14,419,000 | 100.00% | 0.14% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | F | Common Stock | 5871 | $14.96 | 223,192.0000 | 14,419,000 | 2.56% | 0.04% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | Not found | M | Common Stock | 20001 | $0.00 | 229,063.0000 | 14,419,000 | 9.57% | 0.14% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 24761 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.05% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 18068 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.04% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 24984 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.05% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Common Stock | 5000 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.01% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 36690 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.08% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 6432 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.01% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 12155 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.03% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 5017 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.01% |
| Aug. 5, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 13928 | $0.00 | 0.0000 | 47,701,161 | 100.00% | 0.03% |
| May 22, 2025 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Common Stock | 5000 | $0.00 | 5,000.0000 | 46,671,534 | 9999.99% | 0.01% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Restricted Stock Unit | 71403 | $0.00 | 71,403.0000 | 14,721,000 | 9999.99% | 0.49% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 25132 | $0.00 | 221,214.0000 | 14,721,000 | 12.82% | 0.17% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 12152 | $15.91 | 209,062.0000 | 14,721,000 | 5.49% | 0.08% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Restricted Stock Unit | 73559 | $0.00 | 73,559.0000 | 14,721,000 | 9999.99% | 0.50% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 25132 | $0.00 | 50,263.0000 | 14,721,000 | 33.33% | 0.17% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 12675 | $16.79 | 196,082.0000 | 14,721,000 | 6.07% | 0.09% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 30060 | $0.00 | 208,757.0000 | 14,721,000 | 16.82% | 0.20% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 30060 | $0.00 | 0.0000 | 14,721,000 | 100.00% | 0.20% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 20002 | $0.00 | 184,568.0000 | 14,721,000 | 12.15% | 0.14% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 5871 | $16.62 | 178,697.0000 | 14,721,000 | 3.18% | 0.04% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 20002 | $0.00 | 20,001.0000 | 14,721,000 | 50.00% | 0.14% |
| June 5, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Award (Right to Buy) | 18068 | $0.00 | 18,068.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Award (Right to Buy) | 13928 | $0.00 | 13,928.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 13928 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Award (Right to Buy) | 6432 | $0.00 | 6,432.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 5017 | $9.63 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Award (Right to Buy) | 12155 | $0.00 | 12,155.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 12155 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Award (Right to Buy) | 5017 | $0.00 | 5,017.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | D | Stock Option Award (Right to Buy) | 6432 | $7.62 | 0.0000 | 0 | 100.00% | 0.00% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Restricted Stock Unit | 75395 | $0.00 | 75,395.0000 | 14,656,000 | 9999.99% | 0.51% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Stock Option (Right to Buy) | 182699 | $0.00 | 182,699.0000 | 14,656,000 | 9999.99% | 1.25% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 20001 | $0.00 | 154,384.0000 | 14,656,000 | 14.88% | 0.14% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 6473 | $25.42 | 147,911.0000 | 14,656,000 | 4.19% | 0.04% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 30059 | $0.00 | 177,970.0000 | 14,656,000 | 20.32% | 0.21% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 14534 | $25.79 | 163,436.0000 | 14,656,000 | 8.17% | 0.10% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 14420 | $0.00 | 0.0000 | 14,656,000 | 100.00% | 0.10% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 20001 | $0.00 | 40,003.0000 | 14,656,000 | 33.33% | 0.14% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 14420 | $0.00 | 141,356.0000 | 14,656,000 | 11.36% | 0.10% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 30059 | $0.00 | 30,060.0000 | 14,656,000 | 50.00% | 0.21% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 6973 | $25.42 | 134,383.0000 | 14,656,000 | 4.93% | 0.05% |
| March 1, 2024 | Vigil Neuroscience, Inc. | $VIGL | Blanchard Cheryl R | Not found | A | Stock Option Grant (Right to Buy) | 24761 | $0.00 | 24,761.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | Dare Bioscience, Inc. | $DARE | Blanchard Cheryl R | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,068,790 | 9999.99% | 0.57% |
| April 26, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 24575 | $0.00 | 0.0000 | 14,787,000 | 100.00% | 0.17% |
| April 26, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 24575 | $0.00 | 136,897.0000 | 14,787,000 | 21.88% | 0.17% |
| April 26, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 10900 | $26.34 | 125,997.0000 | 14,787,000 | 7.96% | 0.07% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 30060 | $0.00 | 125,533.0000 | 14,787,000 | 31.49% | 0.20% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 30060 | $0.00 | 60,119.0000 | 14,787,000 | 33.33% | 0.20% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 13211 | $26.10 | 112,322.0000 | 14,787,000 | 10.52% | 0.09% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Restricted Stock Unit | 14419 | $0.00 | 14,420.0000 | 14,787,000 | 50.00% | 0.10% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | F | Common Stock | 4232 | $26.91 | 95,473.0000 | 14,787,000 | 4.24% | 0.03% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | M | Common Stock | 14419 | $0.00 | 99,705.0000 | 14,787,000 | 16.91% | 0.10% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Restricted Stock Unit | 60004 | $0.00 | 60,004.0000 | 14,787,000 | 9999.99% | 0.41% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Blanchard Cheryl R | President, CEO, Director | A | Stock Option (Right to Buy) | 130998 | $0.00 | 130,998.0000 | 14,787,000 | 9999.99% | 0.89% |